Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Badger Meter
BMI
$4.03B
| $2.99M | ﹤0.01% |
46,066
+4,971
| +12% | +$295K |
|
2552
Enanta Pharmaceuticals
ENTA
$400M
| $2.99M | ﹤0.01% |
48,370
+12,115
| +33% | +$751K |
|
2553
Boise Cascade
BCC
$3.02B
| $2.99M | ﹤0.01% |
81,772
+17,709
| +28% | +$643K |
|
|
INOV
2554
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $2.99M | ﹤0.01% |
158,735
+68,379
| +76% | +$1.14M |
|
2555
Box
BOX
$4.6B
| $2.98M | ﹤0.01% |
177,648
+98,605
| +125% | +$1.65M |
|
|
NATI
2556
DELISTED
National Instruments Corp
NATI
| $2.98M | ﹤0.01% |
70,424
+17,931
| +34% | +$750K |
|
|
WIFI
2557
DELISTED
Boingo Wireless, Inc.
WIFI
| $2.98M | ﹤0.01% |
272,269
-24,862
| -8% | -$270K |
|
2558
Novanta
NOVT
$6.29B
| $2.98M | ﹤0.01% |
33,690
+17,088
| +103% | +$1.47M |
|
2559
PUT
iQIYI
IQ
$1.28B
| $2.97M | ﹤0.01% |
140,900
-105,500
| -43% | -$1.94M |
|
2560
FLEX LNG
FLNG
$1.67B
| $2.97M | ﹤0.01% |
272,872
+30,934
| +13% | +$309K |
|
2561
CarGurus
CARG
$3.47B
| $2.97M | ﹤0.01% |
84,454
+41,023
| +94% | +$1.45M |
|
|
CVET
2562
DELISTED
Covetrus, Inc. Common Stock
CVET
| $2.97M | ﹤0.01% |
224,876
+179,782
| +399% | +$2.18M |
|
|
GWB
2563
DELISTED
Great Western Bancorp, Inc.
GWB
| $2.97M | ﹤0.01% |
85,445
+28,647
| +50% | +$990K |
|
2564
Shenandoah Telecom
SHEN
$746M
| $2.97M | ﹤0.01% |
71,285
+35,594
| +100% | +$1.26M |
|
|
ARCH
2565
DELISTED
Arch Resources, Inc.
ARCH
| $2.96M | ﹤0.01% |
41,311
+22,684
| +122% | +$1.74M |
|
|
NBIS
2566
CALL
Nebius Group N.V.
NBIS
$47.7B
| $2.96M | ﹤0.01% |
68,100
-95,500
| -58% | -$3.56M |
|
2567
Ormat Technologies
ORA
$6.65B
| $2.96M | ﹤0.01% |
39,725
+18,162
| +84% | +$1.37M |
|
2568
Dillards
DDS
$9.56B
| $2.96M | ﹤0.01% |
40,237
+7,206
| +22% | +$511K |
|
|
DFVS
2569
DELISTED
iPath US Treasury 5-year Bear ETN
DFVS
| $2.95M | ﹤0.01% |
108,400
| – | – |
|
|
JJA
2570
DELISTED
iPath Series B Bloomberg Agriculture Subindex Total ReturnSM ETN
JJA
| $2.95M | ﹤0.01% |
195,000
-75,000
| -28% | -$1.09M |
|
2571
COPT Defense Properties
CDP
$4.21B
| $2.94M | ﹤0.01% |
100,257
-57,721
| -37% | -$1.68M |
|
|
ABTX
2572
DELISTED
Allegiance Bancshares
ABTX
| $2.94M | ﹤0.01% |
78,303
+68,429
| +693% | +$2.41M |
|
2573
PUT
Cencora
COR
$61.2B
| $2.94M | ﹤0.01% |
34,600
-9,700
| -22% | -$831K |
|
2574
TTM Technologies
TTMI
$14.5B
| $2.94M | ﹤0.01% |
195,287
+59,725
| +44% | +$785K |
|
2575
Rhythm Pharmaceuticals
RYTM
$7.96B
| $2.94M | ﹤0.01% |
127,847
+113,881
| +815% | +$2.53M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.